Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Witt

Showing results (41-50 of 242) with videos related to

Pageof 25
Sort By:
BMC Cancer|August 25, 2010
Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment conceptStefan Rieken, Timo Gaiser, Angela Mohr, et al.
Journal of Neuro-Oncology|January 7, 2024
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cellsSimon Zeuner, Johanna Vollmer, Romain Sigaud, et al.
Cancer Letters|July 16, 2008
Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cellsJohannes H Schulte, Jutta Kirfel, Soyoung Lim, et al.
Neuro-Oncology|September 22, 2023
Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translationTill Milde, Jason Fangusaro, Michael J Fisher, et al.
World Neurosurgery|March 5, 2023
Cerebellar Mutism Syndrome After Posterior Fossa Tumor Surgery in Children-A Retrospective Single-Center StudyStephanie Schmidt, Edina Kovacs, Diren Usta, et al.
International Journal of Cancer|January 21, 2010
Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cellsJeannine Lacroix, Barbara Leuchs, Junwei Li, et al.
Cancer Letters|February 12, 2008
Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitroHedwig E Deubzer, Volker Ehemann, Andreas E Kulozik, et al.
Journal of Pediatric Hematology/Oncology|April 7, 2009
13-cis retinoic acid treatment of a patient with chemotherapy refractory nephroblastomatosisOlaf Witt, Susanne Hämmerling, Clemens Stockklausner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 2011
Outcome and prognostic factors of radiation therapy for medulloblastomaStefan Rieken, Angela Mohr, Daniel Habermehl, et al.
Molecular Oncology|October 1, 2022
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoproteinLisa Rösch, Sonja Herter, Sara Najafi, et al.
Pageof 25

Showing results (41-50 of 242) with videos related to

Sort By:
Pageof 25
BMC Cancer|August 25, 2010
Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment conceptStefan Rieken, Timo Gaiser, Angela Mohr, et al.
Journal of Neuro-Oncology|January 7, 2024
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cellsSimon Zeuner, Johanna Vollmer, Romain Sigaud, et al.
Cancer Letters|July 16, 2008
Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cellsJohannes H Schulte, Jutta Kirfel, Soyoung Lim, et al.
Neuro-Oncology|September 22, 2023
Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translationTill Milde, Jason Fangusaro, Michael J Fisher, et al.
World Neurosurgery|March 5, 2023
Cerebellar Mutism Syndrome After Posterior Fossa Tumor Surgery in Children-A Retrospective Single-Center StudyStephanie Schmidt, Edina Kovacs, Diren Usta, et al.
International Journal of Cancer|January 21, 2010
Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cellsJeannine Lacroix, Barbara Leuchs, Junwei Li, et al.
Cancer Letters|February 12, 2008
Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitroHedwig E Deubzer, Volker Ehemann, Andreas E Kulozik, et al.
Journal of Pediatric Hematology/Oncology|April 7, 2009
13-cis retinoic acid treatment of a patient with chemotherapy refractory nephroblastomatosisOlaf Witt, Susanne Hämmerling, Clemens Stockklausner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 2011
Outcome and prognostic factors of radiation therapy for medulloblastomaStefan Rieken, Angela Mohr, Daniel Habermehl, et al.
Molecular Oncology|October 1, 2022
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoproteinLisa Rösch, Sonja Herter, Sara Najafi, et al.
Pageof 25